Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 6, 2022
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
Mon, December 5, 2022
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
Sean Lee Initiated (AKTX) at Strong Buy and Held Target at $30 on, Dec 5th, 2022
Sean Lee of HC Wainwright & Co., Initiated "Akari Therapeutics, Plc" (AKTX) at Strong Buy and Held Target at $30 on, Dec 5th, 2022.
Sean has made no other calls on AKTX in the last 4 months.
There is 1 other peer that has a rating on AKTX. Out of the 1 peers that are also analyzing AKTX, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $80 on, Tuesday, November 1st, 2022
